Carsten Gotfredsen
Overview
Explore the profile of Carsten Gotfredsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gram D, Fribo J, Nagy I, Gotfredsen C, Charrua A, Hansen J, et al.
Med Sci (Basel)
. 2019 Jul;
7(8).
PMID: 31344877
With a global prevalence among adults over 18 years of age approaching 9%, Type 2 diabetes mellitus (T2DM) has reached pandemic proportions and represents a major unmet medical need. To...
2.
Madsen L, Knauf J, Gotfredsen C, Pilling A, Sjogren I, Andersen S, et al.
Endocrinology
. 2012 Jan;
153(3):1538-47.
PMID: 22234463
Liraglutide and exenatide are glucagon-like peptide receptor (GLP-1R) agonists used in the treatment of type 2 diabetes. Both molecules have been associated with the development of thyroid C-cell tumors after...
3.
Knudsen L, Madsen L, Andersen S, Almholt K, DE Boer A, Drucker D, et al.
Endocrinology
. 2010 Mar;
151(4):1473-86.
PMID: 20203154
Liraglutide is a glucagon-like peptide-1 (GLP-1) analog developed for type 2 diabetes. Long-term liraglutide exposure in rodents was associated with thyroid C-cell hyperplasia and tumors. Here, we report data supporting...